PriceTracker GLP-1

GLP-1 TV · News & media · views checked Oct 2026

Tirzepatide or Retatrutide? Analyzing the Newest Clinical Data

News & mediaOn The Pen™ GLP-1 News11,520 views17:01May 2026

Our summary

A news or media piece explains how Zepbound works and what the evidence says, mentioning 15 mg. Side effects mentioned: nausea, vomiting, constipation, diarrhea and bloating. Also covers injection technique, cost and insurance and the trials ($10,000 a month mentioned).

General education as published by the channel. Not medical advice, and not an endorsement.

Key moments

Where the talk turns, found in the captions. Tap one to play from there.

  1. 0:35 Injection technique
  2. 2:29 Dose change
  3. 5:47 Side effects
  4. 6:24 Dose change
  5. 10:47 Side effects
  6. 14:07 Cost and insurance

What the video says

As stated in the video, not checked by us. Doses and results are the speaker’s, not advice.

Medication
Zepbound, tirzepatide and retatrutide
Doses mentioned
15 mg
Side effects mentioned
nausea, vomiting, constipation, diarrhea and bloating
Prices mentioned
$10,000 a month
Who is speaking
News or media

Find more like it

Side effectsDose changeInjection techniqueCost and insuranceThe trialsNauseaVomitingConstipationDiarrheaBloating

Up next

More from this collection

Watched it? See what it costs.

Every GLP-1 program we track, ranked by what actually leaves your account.

Back to GLP-1 TV